Condensed Consolidated Statements of Operations - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
Dec. 31, 2016 |
Dec. 31, 2015 |
|
| Income Statement [Abstract] | ||||||
| Product revenue | $ 2,956 | $ 3,378 | $ 8,793 | $ 11,574 | $ 15,226 | $ 19,453 |
| Costs of revenue | 1,408 | 765 | 2,791 | 2,675 | 3,777 | 6,250 |
| Gross profit | 1,548 | 2,613 | 6,002 | 8,899 | 11,449 | 13,203 |
| Operating expenses: | ||||||
| Research and development | 1,433 | 1,582 | 3,790 | 4,743 | 6,345 | 6,387 |
| General and administrative | 1,092 | 1,912 | 3,288 | 4,834 | 6,292 | 6,436 |
| Sales and marketing | 1,579 | 2,326 | 5,005 | 7,514 | 10,347 | 12,421 |
| Total operating expenses | 4,104 | 5,820 | 12,083 | 17,091 | 22,984 | 25,244 |
| Loss from operations | (2,556) | (3,207) | (6,081) | (8,192) | (11,535) | (12,041) |
| Other income (expenses): | ||||||
| Interest expense | (270) | (745) | (1,008) | (3,998) | (4,511) | (4,339) |
| Loss on extinguishment of debt | (417) | (661) | (661) | 2,171 | ||
| Change in fair value of derivative liabilities | 756 | (252) | 2,938 | (228) | 2,476 | (7,605) |
| Loss on extinguishment of derivative liabilities | (1,263) | |||||
| Offering costs | (571) | (131) | (571) | (571) | (821) | |
| Other income | 1 | 5 | (2) | 11 | 39 | (14) |
| Total other income (expense), net | 487 | (1,980) | 1,797 | (5,447) | (3,228) | (11,871) |
| Net loss before income taxes | (2,069) | (5,187) | (4,284) | (13,639) | (14,763) | (23,912) |
| Provision for income taxes | ||||||
| Net loss | (2,069) | (5,187) | (4,284) | (13,639) | (14,763) | (23,912) |
| Deemed dividend related to beneficial conversion feature and accretion of a discount on Series A Preferred Stock | (6,278) | (6,278) | (6,278) | |||
| Net loss attributable to common stockholders | $ (2,069) | $ (11,465) | $ (4,284) | $ (19,917) | $ (21,041) | $ (23,912) |
| Net loss per share | ||||||
| Basic and diluted | $ (0.68) | $ (5.97) | $ (1.47) | $ (15.21) | $ (13.63) | $ (66.05) |
| Weighted average common shares outstanding: | ||||||
| Basic and diluted | 3,022,073 | 1,920,745 | 2,918,240 | 1,309,286 | 1,543,735 | 362,021 |
| X | ||||||||||
- Definition Loss on extinguishment of derivative liabilities. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer). No definition available.
|
| X | ||||||||||
- Definition Amount of interest expense classified as other. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Includes offering costs of open-end investment companies, and closed-end funds with a continuous offering period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|